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Abstract
Selectins are glycan-binding adhesion molecules which mediate the initial steps of leukocyte 
recognition of endothelium. Cytokines control numerous aspects of CD4 T helper differentiation, 
but how cytokines control induction of ligands for E- and P-selectin on T helper subsets remains 
poorly understood. Among 20 cytokines that affect T helper cell differentiation, we identified six, 
IL-12, IL-18, IL-27, IL-9, IL-25 and TGFβ1, that induce expression of selectin ligands on murine 
CD4 T cells above the low levels associated with TCR engagement. Collectively, these six 
cytokines could potentially account for selectin ligand expression on all of the currently defined 
non-sessile T helper lineages, including Th1, Th2, Th9, Th17 and Treg. Induction of selectin 
ligand expression by each of these six cytokines was almost completely inhibited by 
pharmacologic inhibition of p38 MAPK, but not other MAPKs, or by conditional genetic deletion 
of p38 alpha MAPK. Analysis of the expression of key glycosyltransferase genes revealed that 
p38 alpha signaling was selectively required for induction of Fut7 and Gcnt1, but not for induction 
of St3gal4 or St3gal6. Constitutively active MKK6, an immediate upstream activator of p38 
MAPK, induced selectin ligand expression equivalent to that of cytokines, and this induction was 
completely dependent on expression of p38 alpha. Our results identify the repertoire of cytokines 
responsible for selectin ligand induction on CD4 T cells and provide a mechanistic link between T 
helper development and T cell migration.
INTRODUCTION
Ag-stimulated CD4 T cell differentiation leads to a number of functionally distinct cell fates 
that are determined primarily by cytokines in the extracellular milieu. Among six defined T 
helper (Th) cell lineages, Th1, Th2, Th17, and Th9 are defined by their signature cytokines 
IFNγ, IL-4, IL-17 and IL-9, respectively, and mediate both protective immunity to specific 
classes of pathogens as well as distinct types of inflammation (1–4). T follicular helper (Tfh) 
cells provide essential help for B cells in the germinal center (5,6), and regulatory T cells 
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(Treg) are essential components of immunologic tolerance (7,8). Each of these six lineages 
also requires specific cytokines and corresponding sets of transcription factors to promote 
their development and preclude the development of alternative fates, with three of these 
(Th17, Th9 and Treg) sharing a requirement for signaling by TGFβ1 (9–11). With the 
exception of Tfh cells, which are mostly sessile and confined to germinal centers, cells of 
each of the other lineages require the ability to access peripheral tissues for their effector 
function. However, despite an abundance of information on transcription factors and 
cytokines which positively or negatively regulate these Th cell fate choices, mechanisms 
which control the ability of each Th cell subset to migrate to peripheral sites of inflammation 
remain largely undefined.
Selectins are a family of three glycan-binding adhesion molecules that mediate the initial 
steps of tethering and rolling on endothelium during migration to secondary lymphoid 
organs and sites of inflammation (12–14). E- and P-selectin (CD62E and CD62P) are 
inducibly expressed on endothelium at sites of inflammation and are critical for recruitment 
of all classes of leukocytes. Glycans that function as selectin ligands are absent from naive T 
cells and are inducibly expressed on CD4 cells as a function of both TCR engagement and 
the cytokine milieu (15,16). IL-12 is a potent inducer of selectin ligands on activated CD4 
cells, whereas IL-4 either has no effect or actively inhibits selectin ligand expression (15–
17). TGFβ1 is also a potent inducer of selectin ligand expression on CD4 T cells in both 
humans and mice (18,19). However, other cytokines that might play a role in regulation of 
selectin ligand expression have not been identified, and signal transduction pathways that 
underlie the ability of IL-12 or TGFβ1 to induce selectin ligands are incompletely 
understood.
We screened a large panel of cytokines known to regulate T cell function and identified a 
subset which induce selectin ligand expression. While highly disparate in their canonical 
signaling mechanisms, these six T helper-promoting cytokines each activate p38 MAP 
kinase and require p38 MAPK activity for selectin ligand induction. Moreover, p38 MAPK 
activity was mediated exclusively by the p38 alpha isoform, and was selectively required for 
expression of only a subset of relevant glycosyltransferases (GTases). These results identify 
cytokines capable of selectin ligand induction on all defined classes of T helper cells, and 
identify a common pathway through which they function.
MATERIALS & METHODS
Mice
WT C57BL/6 mice were originally obtained from Jackson Labs and were maintained in our 
colony under specific pathogen-free conditions. Mice with a “floxed” p38 alpha allele were 
kindly provided by Dr. Mercedes Rincon, University of Vermont, and were crossed with 
mice expressing the cre recombinase under the control of the CD4 locus, which were 
originally obtained from Jackson Labs and maintained in our colony. For all experiments 
involving mice with conditional deletion of p38 alpha, cre-negative littermates were used as 
controls. Mice of both genders were used, and were matched within an experiment, and no 
differences between genders were observed. All experiments were approved by the 
Northwestern University IACUC.
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T cell activation and culture
Splenic CD4 T cells isolated from WT C57BL6 mice by positive selection using CD4 
magnetic beads (Miltenyi) were activated for ~40 hrs by plate-bound anti-CD3/anti-CD28, 
and cultured with the indicated cytokines (see Fig 1 legend) as described (17,20), with or 
without pharmacologic inhibitors. Cytokines were added either at the initiation of culture, or 
following addition of pharmacologic inhibitors (or vehicle only; see figure legends) or 
retroviral transduction, as indicated in each figure legend. Ecotropic recombinant retrovirus 
was produced by transfecting Phoenix-Eco cells. Activated T cells were transduced by 
spinfection on day 2 of activation with supernatants containing recombinant retrovirus 
encoding eGFP plus either no cDNA, dominant negative (DN) p38 MAPK, or constitutively 
active (ca) MKK6, Rac1 or Rac2, as described (21). For all cultures, cells were harvested 
every 2 days, analyzed by FACS, and recultured in fresh media with (DN p38, inhibitors) or 
without (caMKK6, caRac1, caRac2) cytokines. Cytokines (see fig 1 legend for 
concentrations used) were all murine except TGFβ1 and were from Peprotech (IL-2, IL-4, 
IL-6, IL-7, IL-9, IL-12, IL-15, IL-21, IL-23); Ebioscience (IL-10, IFNγ, IL-27, TNFα); 
R&D Systems (TGFβ1, TSLP, IFNβ); Reprokine (IL-18, IL-25); or Axxora (IL-33).
Flow cytometry
Expression of E- and P-selectin ligands on T cells was determined by staining with E- or P-
selectin/IgM chimeras followed by AF647-anti-human IgM, as described (17,19). We and 
others have previously shown that staining with these selectin chimeras closely and 
quantitatively tracks the ability of cells to roll on these selectins (15,17,18,20,22–24). Live/
dead gating was with Sytox blue. Retrovirally transduced cells were identified by eGFP 
expression. Data was collected on a BD FACS Canto and analyzed using Flojo software.
Western blotting
Western blotting of whole cell lysates representing 1–2 × 106 cells for either total or 
phospho-p38 MAPK was as described (17).
qRT-PCR
Total RNA was isolated from CD4 cells on day 8 using Trizol, and 1 μg was reverse 
transcribed using the Superscript III system and random hexamers. cDNA was amplified and 
quantitated with SYBR green using primers specific for mouse St3gal4, St3gal6, Fut7 and 
Gcnt1. Data were normalized to the housekeeping gene Hprt, and further normalized by 
assigning the normalized value for each gene in the absence of cytokines or inhibitors to 1.
Statistical analysis
Comparison between groups was by Multiple t test within Prizm 6.
RESULTS
Identification of selectin ligand-inducing cytokines
We selected a panel of cytokines based on their ability to affect T helper differentiation, and 
tested them individually or in physiologically relevant combinations for their ability to 
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induce selectin ligands above the low levels associated with T cell activation alone. We 
included IL-2 in all cultures, because inclusion of IL-2 does not alter the level of selectin 
ligands on viable CD4 T cells but does increase cell yield and viability (data not shown). 
This screen identified six T helper promoting cytokines exhibiting strong selectin ligand-
inducing activity: IL-12, IL-18, IL-27, IL-9, IL-25, and TGFβ1 (Fig 1). No cytokines 
selectively induced only E- or P-selectin ligands. Selectin ligand expression on CD4 T cells 
cultured with TGFβ1 was not altered by inclusion of IL-6, and IL-6 alone had no significant 
selectin ligand-inducing activity, nor did other STAT3-activating cytokines, including IL-10 
and IL-21. IL-4 inhibited selectin ligand induction by TGFβ1. Because IL-4 does not induce 
selectin ligand expression, how Th2 cells in vivo express selectin ligands (25,26) has been 
enigmatic. Our finding that IL-25, known to promote Th2 development (27), is a strong 
inducer of selectin ligands therefore suggests that IL-25 could be the major physiologic 
inducer of selectin ligands on Th2 cells in vivo. Although IL-9 is not known to promote the 
development of specific T helper lineages on its own, autocrine IL-9 could amplify selectin 
ligand expression on Th9 or Th2 cells. Other γc-activating cytokines, including IL-2, IL4, 
IL-7 and IL-15, had no significant effect. IL-21 and IL-23, both of which promote Th17 
generation and/or expansion (28), were without effect. Notably, both IFNβ and IFNγ were 
without effect, despite being potent inducers of T-bet (29), which is critical for selectin 
ligand induction in response to IL-12 (20). For each of these cytokines, selectin ligands were 
expressed on a distinct subpopulation of cells (Fig 2A), and exhibited identical kinetics of 
expression, with the percentage of cells expressing selectin ligands increasing throughout 
the culture until at least day 10 (Fig 2B). Dose response curves (Fig 2C) showed that the 
doses used were near maximal. Together, these results identify a restricted subset of 
cytokines that collectively could account for selectin ligand induction on each of the 
currently defined non-sessile T helper lineages.
Cytokines induce selectin ligands on CD4 cells via p38 alpha MAPK
Induction of selectin ligands on human CD4 T cells in response to TGFβ1 is blocked by 
SB203580, a specific pyrimidazole inhibitor of p38 MAP kinase (18). IL-12, IL-18 and 
IL-27 are also known to activate p38 MAPK (30–32). We therefore asked whether p38 
MAPK was a common pathway for selectin ligand induction by these six cytokines. CD4 T 
cells were activated by anti-CD3/CD28 overnight in the absence of cytokines to enhance 
cytokine responsiveness, rested for 6 hours, and then cultured with the six selectin ligand-
inducing cytokines for 15 min. Each of the six cytokines strongly activated p38 MAPK, and 
for each cytokine this effect was dependent on prior T cell activation (Fig 3A).
We then activated CD4 T cells with anti-CD3/CD28 in the absence of cytokines, and then 
cultured them with each of the six cytokines in the presence or absence of specific inhibitors 
of different MAPK pathways. Selectin ligand induction in response to each of these six 
cytokines was nearly completely blocked by 5 μM SB203580 (Fig 3B), but was not affected 
by pharmacologic inhibition of either ERK MAPK activation by 10 μM PD98059 (Fig 3C) 
or JNK MAPK activation by 5 μM SP100265 (Fig 3D). No defects in T cell proliferation or 
viability were observed in cultures containing SB203580 (data not shown). Because this 
dose of SB203580 was reported to also affect the PI3K pathway (33), we directly tested 
whether pharmacologic inhibition of PI3K by GSK1059615 would have any effect on 
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selectin ligand induction in response to these cytokines, and found that it did not (Fig 3E). In 
addition, retroviral overexpression of a DN p38 also blocked selectin ligand induction in 
response to all six cytokines (data not shown). These results indicate that the p38 MAPK 
pathway is selectively involved in selectin ligand induction in response to diverse 
inflammatory cytokines.
Four p38 isoforms, p38α, p38β, p38γ, and p38δ, have been identified, three of which (p38α, 
p38β, and p38δ) are expressed in CD4 T cells (34). Of the expressed isoforms, p38β is 
expressed at very low levels (34), and p38δ is insensitive to inhibition by SB203580 (35). 
Taken together, these considerations clearly implicate p38α as the primary isoform 
responsible for cytokine-induced selectin ligand expression. To test this, we analyzed CD4 T 
cells from mice with a conditional deletion of p38α driven by CD4-cre. Consistent with 
previous reports (36–38), these mice exhibit no detectable alterations in T cell development 
or in peripheral CD4 or CD8 T cell numbers (data not shown). CD4 T cells were isolated 
from cre+ and cre-negative littermates and analyzed as above for selectin ligand induction 
by these six cytokines. The results (Fig 4) show that conditional genetic inactivation of p38α 
in T cells abrogates the expression of selectin ligands in response to these six cytokines, 
phenocopying the results obtained with pharmacologic inhibition. Taken all together, our 
results offer strong evidence that p38α MAPK is required for selectin ligand induction on 
CD4 T cells in response to this panel of cytokines.
p38α MAPK is required for induction of Fut7 and Gcnt1
To identify mechanisms of p38 MAPK-dependent selectin ligand induction, we next 
examined expression of glycosyltransferases (GTases) known to be involved in selectin 
ligand biosynthesis in murine CD4 T cells (39–41). CD4 T cells activated and cultured with 
each of the six cytokines or IL-2 only, both with and without SB203580, were analyzed by 
qRT-PCR for expression of genes encoding Fut7, Gcnt1, St3gal4 and St3gal6. The results 
(Fig. 5) show that expression of each of these GTase genes was coordinately increased by 
these six cytokines, with the most potent induction in response to IL-12 and TGFβ1, roughly 
corresponding to the percentage of selectin ligand-positive cells generated in the presence of 
each cytokine (Fig 1). Inhibition of p38 MAPK by SB203580 strongly inhibited expression 
of Fut7 and Gcnt1, but had no significant effect on St3gal4 or St3gal6 (Fig 5). Essentially 
identical results were obtained using p38α-deficient CD4 T cells, where we also observed 
strong inhibition of Fut7 and Gcnt1 gene expression, but no significant effect on St3gal4 or 
St3gal6 (Fig 6). These results show that p38α MAPK signaling is selectively required for 
cytokine-driven upregulation of two key GTases in response to T helper-promoting 
inflammatory cytokines.
Constitutive activation of p38α is sufficient for induction of selectin ligands
Finally, to determine whether activation of p38 MAPK was sufficient for induction of 
selectin ligands, CD4 T cells were activated and transduced with RV expressing a 
constitutively active (ca) form of MKK6, the immediate upstream activator of p38 MAPK, 
and cultured in the absence of selectin ligand-inducing cytokines. We found that expression 
of caMKK6 induced levels of selectin ligands similar to those of cytokines (Fig 7). Similar 
results were found using caRac1 or caRac2, which activate MEKK4, the upstream activator 
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of MKK6 (Fig 7). To ensure that this response was entirely dependent on p38α, these 
experiments were also carried out with p38α-deficient CD4 cells. Induction of selectin 
ligands by each of these upstream p38 activators was absent in cells deficient in p38α (Fig 
7). Thus, activation of p38α is essential for induction of selectin ligands on CD4 T cells in 
response to these six inflammatory cytokines, and is sufficient for induction of selectin 
ligands in the absence of inducing cytokines.
DISCUSSION
Although cytokines control numerous aspects of the immune response and host defense, 
how cytokines control leukocyte traffic, particularly T cell traffic, remains poorly 
understood. Similarly, it has been known for some time that specific cytokines or 
combinations of cytokines drive the differentiation of specific T helper subsets, but how this 
is integrated into the regulation of T cell migration has been largely unclear. Selectins are 
critically involved in control of T cell traffic, and expression of selectin ligands is critical for 
recruitment of multiple classes of inflammatory T helper cells to migrate to at least the skin 
and gut. Th1 cell migration to the skin during DTH (42,43) and to the gut (44), Th2 cell 
recruitment to the skin in atopic dermatitis (45,46), and Th17 cell migration to the gut 
(47,48), all require selectin ligand expression on inflammatory T cells, and Th9 cells are also 
skin-tropic and proinflammatory (49). Treg also require the ability to access peripheral 
tissues in order to downregulate immune responses (50). Thus, how selectin ligand 
expression is regulated on T helper cells of all classes is a key question in understanding the 
pathogenesis of a range of chronic inflammatory disorders.
In this report, we identify a small group of inflammatory cytokines, IL-12, IL-18, IL-27, 
IL-9, IL-25, and TGFβ1, most of which have defined roles in the differentiation of specific T 
helper subsets, that induce selectin ligands on activated CD4 T cells. We further show that 
induction of selectin ligands by this group of cytokines requires p38 MAPK activity, 
mediated specifically by the p38 alpha isoform, despite otherwise distinct signaling 
mechanisms. Our findings identify a common signaling mechanism underlying expression 
of selectin ligands on distinct classes of CD4 T cells, and provide a foundation for further 
dissecting molecular mechanisms that coordinate regulation of T helper differentiation and T 
helper migration.
Although MAPK p38β is expressed at much lower levels than p38α in CD4 T cells (34), 
more recent research has shown that p38β represents as much as one third of the active, i.e. 
phosphorylated species following activation specifically through the TCR (51). Whether this 
degree of relative phosphorylation of p38β is also induced by cytokines in unknown. As 
mentioned above, p38β activity is also inhibited by SB203580. However, our results using 
p38α conditional knockout mice show clearly that p38α accounts for essentially all of the 
activity in response to cytokines, indicating that p38β plays little or no role in these 
responses. Data showing that caMKK6 or caRac1/2 can induce selectin ligands also suggest 
that cytokines trigger primarily the classical pathway of p38 MAPK activation.
At least four glycosyltransferases contribute to selectin ligand formation: FucT-VII, 
C2GlcNAcT-I, ST3Gal-IV and ST3Gal-VI (39–41,52,53). Although expression of the genes 
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encoding each of these enzymes was upregulated by these six cytokines, we found that only 
Fut7 and Gcnt1 induction are dependent on p38 MAPK signaling. This finding implies that 
these cytokines trigger additional, p38α MAPK-independent signaling pathways that are 
responsible for upregulation of St3gal4 and St3gal6, which will be important to identify. Our 
results implicate Fut7 and Gcnt1 as targets of a p38 alpha MAPK-dependent genetic 
program that controls T cell migration in diverse settings of inflammation.
It is possible that our results could be explained in part by a requirement for p38α MAPK in 
expression of cell surface receptors for the selectin ligand-inducing cytokines we have 
identified. Little is known about signaling pathways that control expression of most of these 
cytokine receptors. However, inhibition of p38 activity does not affect the ability of IL-12 to 
trigger STAT4 phosphorylation (30), and receptors for TGFβ1 are constitutively expressed 
on T cells. In addition, caMKK6 induced high levels of selectin ligand expression which are 
absolutely dependent on p38α MAPK. These findings make it unlikely that inhibition of 
receptor expression is a common mechanism underlying our findings.
IL-12 promotes Th1 development, and both IL-18 and IL-27 can also induce or augment 
Th1 development (31,32,54,55). We and others have previously shown that IL-12 potently 
induces selectin ligands (15–17), and we show here that IL-18 and IL-27 also do so. Th1 
development and selectin ligand induction by IL-12 requires both Stat4 and T-bet 
(17,20,56,57). Like IL-12, IL-18 and IL-27 also induce T-bet (58,59), which may be 
required for selectin ligand induction by these cytokines, and induction of T-bet by these 
cytokines appears to require p38 MAPK signaling (32,60). Also like IL-12, both IL-18 and 
IL-27 are products of APC, suggesting multiple ways through which APC can regulate 
selectin ligand expression in CD4 T cells. Recent evidence indicates that IL-27 may be 
additionally important for modulation of inflammation in part via its ability to induce IL-10 
(61), suggesting a mechanism for maintenance of T cell recruitment during the resolution 
phase of an inflammatory response.
The downstream targets that link p38 MAPK signaling to induction of Fut7 and Gcnt1 in T 
cells are presently unclear, and may not be identical for each of these cytokines. A number 
of widely expressed transcription factors have been identified as direct targets of p38 
MAPK, including ATF-2, CREB, CHOP, MEF2C, Runx, and STATs (62,63). IL-12 induces 
phosphorylation of STAT4 serine 721 by p38 MAPK, and this enhances transcriptional 
potential for a subset of STAT4 gene targets (64), which may include Gcnt1, since STAT4 is 
essential for IL-12-induced expression of Gcnt1 (17). IL-9 and IL-27 activate STAT1, 
STAT3 and/or STAT5 in various cell types, including T cells, suggesting that one or more 
of these STAT proteins could function downstream of IL-9 and IL-27 in selectin ligand 
induction, analogous to STAT4 in IL-12-induced responses. Consistent with this, p38 
MAPK phosphorylates serine 727 in both STAT1 and STAT3, which is homologous to 
serine 721 in STAT4. These serine residues are located in a highly conserved region of the 
transactivation domains of STAT1, STAT3 and STAT4, and p38-mediated phosphorylation 
of serine 727 in STAT1 and STAT3 also enhances their transcriptional activity (65,66).
Distinct mechanisms involving other p38 targets seem likely at least for TGFβ1 and IL-25. 
TGFβ1 signaling utilizes multiple MAPK pathways in addition to Smad transcription 
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factors, and both p38 and ERK MAPK have been shown to phosphorylate Smad proteins 
(67), modulating their activity. Determining whether phosphorylation of Smad proteins by 
p38 alpha MAPK is involved in selectin ligand induction, or whether the requirement for 
p38 MAPK signaling is independent of Smad transcriptional activity, is a key question 
going forward. The E3 ubiquitin ligase Act1/CIKS is an adaptor protein essential for at least 
some signaling through the IL-25R and related family members (68). Act1 couples the 
IL25R to multiple downstream effectors, including Traf6 (69,70). It will be important to 
determine whether Act1, or Traf6, is required for p38 MAPK activation by IL-25. It will 
also be important to determine how the IL9R couples to p38 activation.
In summary, we have shown that a diverse group of inflammatory cytokines can potentially 
collectively account for expression of selectin ligands on all defined murine T helper 
subsets, and that selectin ligand induction in response to these functionally distinct cytokines 
requires p38α MAPK. The undoubtedly diverse mechanisms underlying the requirement for 
p38α MAPK in GTase gene induction in response to these inflammatory cytokines will 
require further investigation. Our results identify p38α MAPK as a common and essential 
pathway through which a select group of cytokines responsible for promoting the 
development of diverse T helper lineages can couple differentiation of specific T helper 
lineages to expression of key homing molecules required for effector function in peripheral 
tissues.
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Fig 1. Cytokines which induce selectin ligands on murine CD4 T cells
CD4+ T cells were activated with plate-bound anti-CD3/CD28 in the presence of the 
indicated cytokines as described in Materials & Methods. FACS analysis for selectin ligands 
was performed every 2 days; results are from day 8. IL-4 (10 ng/ml), IL-6 (20 ng/ml), IL-7 
(10U/ml), IL-9 (20 ng/ml), IL-10 (20 ng/ml), IL-15 (10 ng/ml), IL-18 (50 ng/ml), IL-21 (20 
ng/ml), IL-23 (20 ng/ml), IL-25 (25 ng/ml), IL-27 (100 ng/ml), IL-33 (10 ng/ml), TSLP (10 
ng/ml), IFNγ (10 ng/ml), IFNβ (1000U/ml), TNFα (20 ng/ml), IL-12 (10 ng/ml), TGFβ1 (5 
ng/ml). (A) E-selectin; (B) P-selectin. Values are mean ± SD for n=3. * p<0.01 vs IL-2 
alone. # p<0.01 vs TGFβ1 alone.
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Fig 2. Selectin ligand expression in response to inflammatory cytokines
(A) Representative FACS plots of E- and P-selectin ligands on CD4 T cells cultured with 
each of the six cytokines identified as in Fig 1. (B) Kinetics of expression of selectin ligands 
in response to these six cytokines; doses used are as in fig 1. (C) Dose response curves for 
each cytokine; data are from day 8.
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Fig 3. Selective role of p38 MAPK in cytokine-induced selectin ligand expression
(A) CD4 T cells were either activated with anti-CD3/CD28 (top panels) or not (bottom), 
rested for 6 hours, exposed to the indicated cytokine for 15 min, and whole cell lysates were 
Western blotted for either total or phospho-p38 MAPK as indicated. Representative of 3 
similar experiments. (B-E) CD4 T cells were activated by anti-CD3/CD28 without cytokine 
or inhibitor for 2 days, harvested, and cultured with cytokine plus (B) 5 μM SB203580; (C) 
10 μM PD98059; (D) 5 μM Sp100265; or (E) 10 nM GSK1059615 (filled symbols) or 
vehicle (DMSO) only (open symbols), as described in Materials & Methods; data are from 
day 8. B-D, mean ± SD for 3 (B) or 2 (C-E) experiments. *p<0.01 vs no inhibitor.
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Fig 4. Selectin ligand induction in response to inflammatory cytokines requires p38 alpha
CD4 cells were isolated from p38α cKO mice or their cre-negative littermates and cultured 
with the six cytokines or IL-2 alone as above. FACS analysis was performed every two 
days. Values are mean ± SD for n=3. *p<0.01 vs cre-negative cells.
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Fig 5. Selective inhibition of Fut7 and Gcnt1 by p38 MAPK inhibition
CD4 T cells were activated and cultured with cytokines or IL-2 only in the presence (open 
bars) or absence (closed bars) of 5 μM SB203580 as above, harvested at day 8, resuspended 
in Trizol, and 1 μg of total RNA was reverse transcribed. Expression of Fut7, Gcnt1, 
St3gal4, and St3gal6 was quantitated using SYBR green. Levels of mRNA for each enzyme 
in the absence of cytokines and inhibitors was assigned a value of 1. Values are mean ± SD 
for n=3. *p<0.01 vs IL-2 only group; #, p<0.01 for both groups different from all other 
groups.
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Fig 6. Inhibition of Fut7 and Gcnt1 expression by genetic inactivation of Mapk14
Identical setup as in fig 5, except that instead of cells being treated with SB203580, RNA 
was isolated on day 8 from the p38α MAPK-deficient CD4 and cre-negative control cells in 
fig 4. Values are mean ± SD for n=3. *p<0.01 vs IL-2 only group.
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Fig 7. Induction of selectin ligands in response to caMKK6 requires p38α
CD4+ T cells from p38α MAPK-deficient CD4 and cre-negative control cells were 
activated, transduced with RV expressing caMKK6, caRac1, caRac2, or no cDNA, and 
cultured with IL-2 only. Cells were analyzed by FACS for E-selectin ligands and P-selectin 
ligands as above; data are from day 8. Values are mean ± SD for n=3. *p<0.01 vs ctrl RV.
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